NextCure, Inc. (NXTC) vs Quantum BioPharma Ltd. (QNTM)
A side-by-side comparison of NextCure, Inc. and Quantum BioPharma Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NXTC
NextCure, Inc.
$5.34HealthcareDelayed quote: Oct 6, 2026, 2:44 PM EDT
QNTM
Quantum BioPharma Ltd.
$3.21HealthcareDelayed quote: Oct 6, 2026, 2:43 PM EDT
Total return — NXTC vs QNTM
growth of $100 · dividends reinvested · last 7yNXTC -97.9% (-42.4%/yr)QNTM -99.9% (-61.2%/yr)NXTC compounded faster over this window
Log scale — wide-divergence pair
NXTC QNTM
NXTC vs QNTM: by the numbers
- •QNTM is the larger company ($21M vs $19M market cap).
Metrics side by side
Valuation
| Metric | NXTC | QNTM |
|---|---|---|
| P/B ratio | 1.59 | 2.59 |
Profitability
| Metric | NXTC | QNTM |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -351.86% | -313.46% |
| ROIC | -259.91% | -27.14% |
Growth (annualized)
| Metric | NXTC | QNTM |
|---|---|---|
| Total return CAGR (5Y) | -44.29% | -49.16% |
Frequently asked
- How have NXTC and QNTM total returns compared?
- Over the past 5 years, NXTC delivered -44.29% and QNTM delivered -49.16% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.